SciELO - Scientific Electronic Library Online

 
vol.65 número3Conocimientos sobre prevención y factores de riesgo para cáncer de cuello uterino en un centro de educación técnica índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Peruana de Ginecología y Obstetricia

versión On-line ISSN 2304-5132

Resumen

SEPULVEDA RIVERA, Cintia María et al. Effectiveness of the FIGO protocol for medical management of first-trimester abortion. Rev. peru. ginecol. obstet. [online]. 2019, vol.65, n.3, pp.305-308. ISSN 2304-5132.  http://dx.doi.org/10.31403/rpgo.v66i2186.

Objective: To determine the effectiveness of misoprostol using the International Federation of Gynecology and Obstetrics (FIGO) 2017 protocol for medical management of first trimester abortion. Methods: A cross-sectional study was performed between March and September 2018. Seventy-six patients diagnosed with first trimester spontaneous abortion were managed following the FIGO 2017 protocol for medical management of first trimester abortion. Results: Main indications for inclusion of the 76 patients were missed abortion 57.9%, incomplete abortion 25%, and anembryonic pregnancy 17.1%. Medical induction with misoprostol followed the FIGO 2017 protocol for medical management of first trimester abortion. The most frequent side effect reported was abnormal uterine bleeding associated with pelvic pain (72.3% of patients). Complete uterine evacuation was accomplished in 98.6% of the patients. Conclusion: Misoprostol use in patients with first trimester abortion following the FIGO 2017 protocol was a safe and cost-effective therapeutic option.

Palabras clave : Abortion; spontaneous; Management; medical; Efficacy.

        · resumen en Español     · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons